Biotechnology News

DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform

- La publicación en esta prestigiosa revista, tras un riguroso proceso de revisión por parte de otros expertos del sector, avala el estudio VIRAGE y respalda la evaluación continuada de VCN-01 en el...

东京, Oct. 01, 2026 (GLOBE NEWSWIRE) -- 日本 Omotesando Helene Clinic与韩国 Maison Privé Clinic 已签署合作备忘录（MOU），旨在促进两国之间的医疗交流，并进一步完善海外患者的就医支持体系。 根据本次协议，双方将在多个领域展开合作，包括再生医疗等医疗领域的信息交流、医疗人员交流、患者就诊前后的支持，以及 VVIP...

NEW YORK, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”), a clinical stage biotechnology company focused on developing...

LOS ANGELES, CA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “we” or “us” or “IMMX”), a global leader in relapsed/refractory AL Amyloidosis, today announced the...

WARREN, N.J., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Tevogen Inc. (“Tevogen” or the “Company”) (Nasdaq: TVGN), an integrated healthcare enterprise combining biotechnology, artificial intelligence, and...

Leader in targeted immuno-oncology drug development brings three decades of academic and biopharmaceutical oncology expertise SOUTH SAN FRANCISCO, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Pliant...

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026 Four oral presentations and three posters build upon Phase 3 ABTECT Maintenance and Induction programs in...

Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026 Quatre présentations orales et trois posters s’appuient sur les données issues des...

Longeveron (LGVN) to participate in three upcoming Longevity/Aging investment conferences.